{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:18:47Z","timestamp":1792685927483,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Despite previous research that focused on liver transaminases as predictors of cardiovascular disease, there has been limited research evaluating the predictive value of AST\/ALT ratio in patients with heart failure. We aimed to investigate AST\/ALT ratio as an indicator of the functional severity in chronic heart failure with reduced left ventricular ejection fraction.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Overall, 105 patients previously diagnosed with HFrEF from Buraidah-Al Qassim province, Saudi Arabia were included in this retrospective cross-sectional study. Data on study variables, including demographic data, left ventricular ejection fraction, NYHA class, and AST\/ALT ratio, were collected from patients\u2019 records. The patients were divided into two groups, namely group-1 (AST\/ALT ratio\u2009&lt;\u20091) and group-2 (AST\/ALT ratio\u2009\u2265\u20091), to identify any differences in their cardiac function profiles. NYHA class and NT-proBNP were higher and LVEF was lower in group-2 than in group-1. We found a mild significant correlation between AST\/ALT ratio and APRI, FIB-4 score, NYHA-class, and LVEF (r\u2009=\u20090.2, 0.25, 0.26, and \u2212\u20090.24, respectively; P\u2009&lt;\u20090.05). Multivariate linear regression analysis model and ROC curve showed that AST\/ALT ratio could independently predict HFrEF functional severity with a best cut-off value of 0.9, sensitivity of 43.6%, and specificity of 81.4%.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13104-020-05031-3","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T08:02:29Z","timestamp":1585036949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["AST\/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction"],"prefix":"10.1186","volume":"13","author":[{"given":"Mohammed","family":"Ewid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz S.","family":"Allihimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima A.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawood A.","family":"Aldrewesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Alkuraydis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Abazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"5031_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000659","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019. https:\/\/doi.org\/10.1161\/cir.0000000000000659.","journal-title":"Circulation."},{"issue":"9963","key":"5031_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"M Naghavi","year":"2015","unstructured":"Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(14)61682-2.","journal-title":"Lancet"},{"key":"5031_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.01.005","author":"A Bhardwaj","year":"2010","unstructured":"Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. Am Heart J. 2010. https:\/\/doi.org\/10.1016\/j.ahj.2010.01.005.","journal-title":"Am Heart J."},{"issue":"3","key":"5031_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","volume":"8","author":"SR Motiwala","year":"2015","unstructured":"Motiwala SR, Gaggin HK, Gandhi PU, et al. Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure. J Cardiovasc Transl Res. 2015;8(3):164\u201372. https:\/\/doi.org\/10.1007\/s12265-015-9618-4.","journal-title":"J Cardiovasc Transl Res."},{"issue":"2","key":"5031_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12265-013-9522-8","volume":"7","author":"SR Motiwala","year":"2014","unstructured":"Motiwala SR, Szymonifka J, Belcher A, et al. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res. 2014;7(2):250\u201361. https:\/\/doi.org\/10.1007\/s12265-013-9522-8.","journal-title":"J Cardiovasc Transl Res."},{"issue":"9","key":"5031_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/eurjhf\/hft056","volume":"15","author":"KA Kortekaas","year":"2013","unstructured":"Kortekaas KA, Hoogslag GE, De Boer RA, et al. Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair. Eur J Heart Fail. 2013;15(9):1011\u20138. https:\/\/doi.org\/10.1093\/eurjhf\/hft056.","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"5031_CR7","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.jacc.2016.08.049","volume":"68","author":"NE Ibrahim","year":"2016","unstructured":"Ibrahim NE, Rabideau DJ, Gaggin HK, et al. Circulating concentrations of orexin a predict left ventricular myocardial remodeling. J Am Coll Cardiol. 2016;68(20):2238\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.049.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"5031_CR8","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","volume":"61","author":"MD Samsky","year":"2013","unstructured":"Samsky MD, Patel CB, Dewald TA, et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol. 2013;61(24):2397\u2013405. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.042.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5031_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MCA.0b013e32834e4ef1","volume":"23","author":"DM Lofthus","year":"2012","unstructured":"Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. Coron Artery Dis. 2012;23(1):22\u201330. https:\/\/doi.org\/10.1097\/MCA.0b013e32834e4ef1.","journal-title":"Coron Artery Dis"},{"issue":"19","key":"5031_CR10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/heartjnl-2014-305756","volume":"100","author":"A Alonso","year":"2014","unstructured":"Alonso A, Misialek JR, Amiin MA, et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort. Heart. 2014;100(19):1511\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2014-305756.","journal-title":"Heart"},{"issue":"6","key":"5031_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884.","journal-title":"Gut"},{"issue":"5","key":"5031_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","volume":"58","author":"MV Machado","year":"2013","unstructured":"Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol. 2013;58(5):1007\u201319. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.021.","journal-title":"J Hepatol."},{"issue":"1","key":"5031_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","volume":"93","author":"SG Sheth","year":"1998","unstructured":"Sheth SG, Flamm SL, Gordon FD, Chopra S. AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93(1):44\u20138. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.044_c.x.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5031_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326. https:\/\/doi.org\/10.1053\/jhep.2003.50346.","journal-title":"Hepatology"},{"issue":"1","key":"5031_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u20136. https:\/\/doi.org\/10.1002\/hep.21669.","journal-title":"Hepatology."},{"issue":"4","key":"5031_CR16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatology"},{"issue":"4","key":"5031_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","volume":"145","author":"P Angulo","year":"2013","unstructured":"Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145(4):782\u2013789.e4. https:\/\/doi.org\/10.1053\/j.gastro.2013.06.057.","journal-title":"Gastroenterology"},{"issue":"16","key":"5031_CR18","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/american heart association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5031_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Victor MA, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u201339.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"5031_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/ERP-17-0071","volume":"5","author":"DX Augustine","year":"2018","unstructured":"Augustine DX, Augustine DX, Coates-bradshaw LD, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2018;5(3):11\u201324.","journal-title":"Echo Res Pract."},{"issue":"5","key":"5031_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3892\/ijmm","volume":"23","author":"B Glinghammar","year":"2009","unstructured":"Glinghammar B, Rafter I, Lindstr\u00f6m AK, Hedberg JJ, Andersson HB, Lindblom P, Berg AL, Cotgreave I. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int J Mol Med. 2009;23(5):621\u201331. https:\/\/doi.org\/10.3892\/ijmm.","journal-title":"Int J Mol Med."},{"issue":"6","key":"5031_CR22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2008.64","volume":"16","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity. 2008;16(6):1394\u20139. https:\/\/doi.org\/10.1038\/oby.2008.64.","journal-title":"Obesity."},{"issue":"33","key":"5031_CR23","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.3748\/wjg.v20.i33.11684","volume":"20","author":"C Torruellas","year":"2014","unstructured":"Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20(33):11684\u201399. https:\/\/doi.org\/10.3748\/wjg.v20.i33.11684.","journal-title":"World J Gastroenterol"},{"key":"5031_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcrc.2017.04.040","volume":"41","author":"MM Aboelsoud","year":"2017","unstructured":"Aboelsoud MM, Javaid AI, Al-Qadi MO, Lewis JH. Hypoxic hepatitis\u2014its biochemical profile, causes and risk factors of mortality in critically-ill patients: a cohort study of 565 patients. J Crit Care. 2017;41:9\u201315. https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.040.","journal-title":"J Crit Care"},{"issue":"4","key":"5031_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2014.11.024","volume":"62","author":"M Lazo","year":"2015","unstructured":"Lazo M, Rubin J, Clark JM, et al. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease. J Hepatol. 2015;62(4):841\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.024.","journal-title":"J Hepatol"},{"key":"5031_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4857917","author":"M Yokoyama","year":"2016","unstructured":"Yokoyama M, Watanabe T, Otaki Y, et al. Association of the aspartate aminotransferase to alanine aminotransferase ratio with BNP level and cardiovascular mortality in the general population: the Yamagata study 10-year follow-up. Dis Markers. 2016. https:\/\/doi.org\/10.1155\/2016\/4857917.","journal-title":"Dis Markers."},{"issue":"43","key":"5031_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000004821","volume":"95","author":"G Zoppini","year":"2016","unstructured":"Zoppini G, Cacciatori V, Negri C, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Med (United States). 2016;95(43):1\u20137. https:\/\/doi.org\/10.1097\/MD.0000000000004821.","journal-title":"Med (United States)."},{"issue":"2","key":"5031_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","volume":"136","author":"CE Ruhl","year":"2009","unstructured":"Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and \u03b3-glutamyltransferase and mortality in the United States Population. Gastroenterology. 2009;136(2):477\u2013485.e11. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.052.","journal-title":"Gastroenterology"},{"issue":"12","key":"5031_CR29","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1161\/ATVBAHA.107.152298","volume":"27","author":"A Fraser","year":"2007","unstructured":"Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women\u2019s Heart and Health study and meta-analysis. Arterioscler Thromb Vasc Biol. 2007;27(12):2729\u201335. https:\/\/doi.org\/10.1161\/ATVBAHA.107.152298.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"5031_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0157517","volume":"11","author":"MT Long","year":"2016","unstructured":"Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The association between non-invasive hepatic fibrosis markers and cardiometabolic risk factors in the Framingham Heart Study. PLoS ONE. 2016;11(6):1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0157517.","journal-title":"PLoS ONE"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-020-05031-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:30:34Z","timestamp":1616545834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5031"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05031-3","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval from the regional research ethics committee was taken prior to commencing the study (Al Qassim providence, Saudi Arabia Ministry of Health, approval number: 20181009).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}